A modest lockdown could add 1.8 million TB cases and 342,000 deaths globally over 5 years.
A new analysis of data from a randomized clinical trial that found that mass distribution of the antibiotic azithromycin to children under 5 years old was associated with reduced childhood mortality in three African countries suggests mortality reduction may be linked to effects on pneumonia, diarrhea, or HIV/AIDS mortality.
The WHO urges nations to maintain continuity of TB services as they respond to COVID-19.
Today Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV case in Al-Kharj, bringing the country's March tally to four infections, after the ministry reported 18 in February and 15 in January.
A massive malaria outbreak in Burundi continues, according to the latest update from the World Health Organization's (WHO) African regional office. Since the last update at the end of October, an additional 1.3 million cases and 479 deaths have been recorded, bringing the outbreak total to more than 8.5 million cases.
San Diego-based biopharmaceutical company Qpex Biopharma today announced it will receive a second round of funding from the Biomedical Advanced Research and Development Authority (BARDA) to develop a portfolio of antibiotics targeting antibiotic-resistant gram-negative bacteria.
Global funding has reached an all-time high but falls far short of what's needed to eliminate TB.
A new report from the European Court of Auditors (ECA) argues that while some progress has been made, European Union (EU) leaders need to do more to address the health burden of antibiotic resistance.
Neonatal intensive care units (NICUs) participating in a quality improvement (QI) collaborative increased adherence to the US Centers for Disease Control and Prevention (CDC) core elements of antibiotic stewardship dramatically and cut antibiotic use by a third, according to a study today in Pediatrics.
The vaccine demonstrated 49.7% protection against progression to active tuberculosis in adults.
